BrosMed Receives FDA Clearance for Tiche™ 0.035” Super High Pressure PTA Balloon Dilatation Catheter
Release time:
2022-07-21
Guangdong, China [July 20, 2022] – BrosMed Medical announced its Tiche™ 0.035” PTA Balloon Dilatation Catheter has received the 510(k) clearance from the U.S. Food & Drug Administration.
Tiche™ is a highly deliverable 0.035-inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. BrosMed plans to launch the product in the United States firstly, it is proposed to get CE certificate soon.
BrosMed developed Tiche™ according to the clinical needs for a low-profile, superior high pressure balloon catheter in full range of sizes. The patented microcrystalline grid balloon technology is facilitate to provide high-pressure, non-compliant dilatation which concentrates force on the lesion and reduces the risk of overexpanding the vessel in a low-profile balloon. The twin layer balloon construction offers a rated burst pressure of up to 24 atmospheres and is the only 7 x 200 mm balloon compatible with a 5 French introducer sheath. Additionally, The dual lumen shaft design will achieves rapid deflation time.
With Balloon diameters varies from 3.0mm to 12.0mm, and usable shaft lengths 40cm, 75cm, 120cm and 135cm, Tiche™ is equipped with 278 sizes to meet various clinical demands.
Tiche™ High Pressure PTA Balloon Dilatation Catheter is recommended for PTA of the peripheral vasculature, including iliac, femoral, popliteal, tibial, peroneal, subclavian and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also recommended for stent dilatation post-deployment in the peripheral vasculature.
The launch of Tiche™ 0.035” PTA Balloon Dilatation Catheter marks a new stage of BrosMed technology level for PTA balloons. For more product information of Tiche™, you can search BrosMed website www.brosmed.com or contact us via e-mail: Sales@brosmed.com.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27